Baylor College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Baylor College of Medicine sits in the top decile of US sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count).
Baylor College of Medicine: 616 sponsored US clinical trials, 93 recruiting.
Baylor College of Medicine sponsors 616 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 376 completed. 59 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Non-Hodgkin Lymphoma, with 7 trials.
Top-decile sponsor footprint
Baylor College of Medicine ranks in the top decile of sponsors by registered trial count (#56 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
376 of 452 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
616 total, page 11 of 13
A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
NCT00717223
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
NCT00539695
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
NCT00579111
Folate Rechallenge
NCT00672360
Screening for Bladder Cancer
NCT00848627
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
NCT00578864
Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
NCT00988364
Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)
NCT00586560
Ziprasidone in Pediatric Bipolar Disorder
NCT00622739
Parental Feeding Styles and Child Dietary Quality
NCT03390621
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
NCT00529841
Selegiline to Zelapar Switch Study in Parkinson Disease Patients
NCT00640159
Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
NCT00425230
Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
NCT00458679
Time to Defibrillation Using Automated External Defibrillators by Pediatric Residents in Simulated Cardiac Arrests
NCT00640354
Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
NCT00419003
Prevalence of Hypogonadism in Male Cancer Patients
NCT00472940
Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia
NCT00435370
Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study
NCT00590122
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
NCT00383786
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
NCT00513240
Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma
NCT00383097
Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer
NCT00403221
The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).
NCT00361946
Assessment of GVG for the Treatment of Methamphetamine Dependence
NCT00506935
Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
NCT00340613
Pregabalin in the Treatment of Essential Tremor
NCT00646451
Treatment of Subarachnoid Hemorrhage With Human Albumin
NCT01747408
Watchful Waiting of Incisional Hernias
NCT00351455
A Study of the Relationship Between Disulfiram and Cocaine Self-administration.
NCT00729300
Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease
NCT00646204
Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer
NCT00616291
Collaborative Care for Heart Failure Patients With the Metabolic Syndrome
NCT00293852
Continuous Subcutaneous Infusion of Pramlintide and Insulin
NCT00291772
Treatment of Subarachnoid Hemorrhage With Human Albumin
NCT00283400
Steroid Treatment for Sickle Cell Pain Crisis
NCT00263562
Phase 1 Intrathecal Topotecan for Neoplastic Meningitis
NCT00674674
Dexmedetomidine in Pediatric Tonsillectomy
NCT01057381
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
NCT00120081
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
NCT00206388
Effect of Curcumin on Lung Inflammation
NCT01514266
Pharmacogenetics of Disulfiram for Cocaine
NCT00149630
Lantus in the Treatment of Type 1 Diabetes Children
NCT00206401
Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation
NCT00656266
Physician Uncertainty Reduction for Hypertension
NCT00201084
Ability to Cope With Type 1 Diabetes
NCT00206362
Novel Treatment for Diastolic Heart Failure in Women
NCT00206232
Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents
NCT00253695
Ability to Cope With Type 1 Diabetes
NCT00206349
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant
NCT00078533
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 173 |
| Phase 2 | 59 |
| Phase 3 | 13 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the Baylor College of Medicine pipeline
93 recruiting of 616 indexed (15% open); 376 completed (61%).
Phase mix: 59 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Non-Hodgkin Lymphoma (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Baylor College of Medicine: open-pipeline peers nationwide
Peers matched on 616 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Baylor College of Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 616 trials (± recruiting share)
- University of Southern California · 617 trials · 16% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Stanford University · 15% recruiting · 1,744 trials
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- 59th Medical Wing · 15% recruiting · 20 trials
Related
What to do with this Baylor College of Medicine page
616 registered trials is a research-attention snapshot, not an endorsement of Baylor College of Medicine or any single study.
- 93 of Baylor College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Non-Hodgkin Lymphoma is the condition Baylor College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Non-Hodgkin Lymphoma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Baylor College of Medicine pipeline card: 616 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.